Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Sales | 1,776 | 115 | 760 | 600 |
| Gross Profit | 1,776 | 115 | 760 | 600 |
| Operating Expenses | 9,514 | 5,606 | 4,020 | 1,810 |
| Operating Income | -7,738 | -5,491 | -3,260 | -1,210 |
| Interest Expense | 94 | 0 | 0 | 20 |
| Other Income | -13,886 | -11,718 | 480 | 0 |
| Pre-tax Income | -21,718 | -17,209 | -2,780 | -1,230 |
| Net Income Continuous | -21,718 | -17,209 | -2,780 | -1,236 |
| Net Income | $-21,718 | $-17,209 | $-2,780 | $-1,230 |
| EPS Basic Total Ops | -177.51 | -159.52 | -26.39 | -20.39 |
| EPS Basic Continuous Ops | -177.71 | -159.41 | -26.38 | -20.23 |
| EPS Diluted Total Ops | -177.51 | -159.52 | -26.39 | -20.39 |
| EPS Diluted Continuous Ops | -177.71 | -159.41 | -26.38 | -20.23 |
| EBITDA(a) | $-7,434 | $-5,075 | $-2,750 | $-1,040 |